Although study groups were smaller for AATD and it is methodologically hard to make direct comparisons due to different study designs, definitions, and underlying prevalence of fibrosis, these data suggest good clinical applicability of VCTE‐LSM in people with AATD due to the Pi*ZZ genotype (Table 2), which was also agreed on in a recent Delphi panel [59]. Here, SERPINA1 is linked to alpha 1-antitrypsin deficiency.